| Report Title | Price | Action |
|---|---|---|
| Papillary Tumor (Oncology) - Drugs in Development, 2021
Papillary Tumor (Oncology) - Drugs in Development, 2021 Summary Papillary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021
Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021 Summary Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021 provides in ...
Published: Apr-2021 | No. of Pages: 110
|
$ 3000 | |
| Voltage Dependent N Type Calcium Channel Subunit Alpha 1B (Voltage Gated Calcium Channel Subunit Alpha Cav2.2 or Brain Calcium Channel III or CACNA1B) - Drugs in Development, 2021
Voltage Dependent N Type Calcium Channel Subunit Alpha 1B (Voltage Gated Calcium Channel Subunit Alpha Cav2.2 or Brain Calcium Channel III or CACNA1B)...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Drugs in Development, 2021
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) ...
Published: Apr-2021 | No. of Pages: 130
|
$ 3000 | |
| Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021
Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021 Summary Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs i...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021
Cells Expressing Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxy...
Published: Apr-2021 | No. of Pages: 110
|
$ 3000 | |
| Voltage Dependent T Type Calcium Channel Subunit Alpha 1G (Voltage Gated Calcium Channel Subunit Alpha Cav3.1 or CACNA1G) - Drugs in Development, 2021
Voltage Dependent T Type Calcium Channel Subunit Alpha 1G (Voltage Gated Calcium Channel Subunit Alpha Cav3.1 or CACNA1G) - Drugs in Development, 2021...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 Summary Cytotoxic T Ly...
Published: Apr-2021 | No. of Pages: 140
|
$ 3000 | |
| Pituitary Tumor (Oncology) - Drugs in Development, 2021
Pituitary Tumor (Oncology) - Drugs in Development, 2021 Summary Pituitary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021
Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogen...
Published: Apr-2021 | No. of Pages: 110
|
$ 3000 | |
| Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021
Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021 Summary Adiponectin Receptor ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021 Summary Interleukin 2 Receptor Subunit Alpha...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021
Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021 Summary Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021
Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) - Drugs in Development, 2021 Su...
Published: Apr-2021 | No. of Pages: 110
|
$ 3000 | |
| Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) - Drugs in Development, 2021
Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) - Drugs in Development, 2021 Summary Aldehyde Dehydro...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Drugs in Development, 2021
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Drugs in Development, 2021 Summary T Cell Su...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021
Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 Summary Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021
Cells Expressing Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 Summary Cells Expressin...
Published: Apr-2021 | No. of Pages: 110
|
$ 3000 | |
| Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021
Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021 Summary Aldose...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Brain Derived Neurotrophic Factor (Abrineurin or BDNF) - Drugs in Development, 2021
Brain Derived Neurotrophic Factor (Abrineurin or BDNF) - Drugs in Development, 2021 Summary Brain Derived Neurotrophic Factor (Abrineurin or BDNF) -...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 |